{"pageContent": "Purpose: We compared the effectiveness of PCA3 (prostate cancer antigen 3) and select comparators for improving initial or repeat biopsy decision making in men at risk for prostate cancer, or treatment choices in men with prostate cancer.", "metaData": {"source": "Update on urology--prostate cancer. 1--The molecular basis for prostatic cancer: how it may influence treatment choice\nhttps://pubmed.ncbi.nlm.nih.gov/7781804/"}}